Symbol="ADVM"
AssetType="Common Stock"
Name="Adverum Biotechnologies Inc"
Description="Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops candidate gene therapy products to treat eye and rare diseases. The company is headquartered in Redwood City, California."
CIK="1501756"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1035 O'BRIEN DRIVE, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="163434000"
EBITDA="-126842000"
PERatio="None"
PEGRatio="0"
BookValue="1.299"
DividendPerShare="0"
DividendYield="0"
EPS="-1.24"
RevenuePerShareTTM="0.036"
ProfitMargin="0"
OperatingMarginTTM="-37.07"
ReturnOnAssetsTTM="-0.271"
ReturnOnEquityTTM="-0.711"
RevenueTTM="3600000"
GrossProfitTTM="-81681000"
DilutedEPSTTM="-1.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="3.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3419.85"
PriceToBookRatio="0.302"
EVToRevenue="3700.64"
EVToEBITDA="0.229"
Beta="0.848"
num_52WeekHigh="2.34"
num_52WeekLow="0.531"
num_50DayMovingAverage="1.784"
num_200DayMovingAverage="1.009"
SharesOutstanding="100575000"
DividendDate="None"
ExDividendDate="None"
symbol="ADVM"
open="1.57"
high="1.67"
low="1.57"
price="1.60"
volume="150560.00"
latest_trading_day="2023-08-18"
previous_close="1.59"
change="0.01"
change_percent="0.6289%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="459797"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="0.68"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="1105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_negative_thumbnail_id_2="510"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="960"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
